ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 288 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $42,000 | -6.7% | 1,201 | +22.4% | 0.00% | – |
| Q1 2022 | $45,000 | -25.0% | 981 | +7.9% | 0.00% | – |
| Q4 2021 | $60,000 | +9.1% | 909 | +4.0% | 0.00% | – |
| Q3 2021 | $55,000 | -21.4% | 874 | +3.6% | 0.00% | -100.0% |
| Q2 2021 | $70,000 | -76.8% | 844 | -81.5% | 0.00% | -66.7% |
| Q1 2021 | $302,000 | -6.2% | 4,557 | +8.5% | 0.00% | -25.0% |
| Q4 2020 | $322,000 | +94.0% | 4,200 | +13.5% | 0.00% | +33.3% |
| Q3 2020 | $166,000 | +7.1% | 3,700 | +5.7% | 0.00% | 0.0% |
| Q2 2020 | $155,000 | +66.7% | 3,500 | 0.0% | 0.00% | +50.0% |
| Q1 2020 | $93,000 | – | 3,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |